Scientists provide a summary of the status of immunotherapy in treating prostate cancer, with a discussion of multiple immune modalities, including vaccines, adoptively transferred T cells, and bispecific T cell engagers.
[Cell Reports Medicine]
Home Newsletters Human Immunology News Prostate Cancer Immunotherapy: Improving Clinical Outcomes With a Multi-Pronged Approach
